Fortress Biotech, Inc. (FBIOP)
$17.41-1.36%Close
BUYRECOVERY · day 7
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $132M
- Beta
- 1.21
- P/E (TTM)
- 0.60
- Short % float
- 0.03%
- Days to cover
- 1.0
- SI change
- +100.0%
- 1W
- -6.30%
- 1M
- -5.59%
- vs SPY 1W
- -6.16%
- vs SPY 1M
- -8.09%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
EARNINGS HISTORY
LOADING…Loading earnings…
Company news
FAQ
- What is LOPJLB’s current signal on FBIOP?
- LOPJLB’s latest quantitative signal on Fortress Biotech, Inc. (FBIOP) is BUY in a RECOVERY regime. Signals are updated daily.
- What market regime is FBIOP in?
- Fortress Biotech, Inc. (FBIOP) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Fortress Biotech, Inc. (FBIOP) do?
- Fortress Biotech, Inc., a biopharmaceutical company, engages in the development and commercialization of biopharmaceutical products. The company markets dermatology products, including Emrosi, a minocycline hydrochloride extended-release capsule for the treatment of rosacea; Qbrexza a medicated cloth towelette for primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug for severe re…